AngioDynamics
ANGO
109 hedge funds and large institutions have $378M invested in AngioDynamics in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 46 reducing their positions, and 13 closing their positions.
492% more call options, than puts
Call options by funds: $8.33M | Put options by funds: $1.41M
6% more capital invested
Capital invested by funds: $355M → $378M (+$23M)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more funds holding
Funds holding: 109 → 109 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$8.06M |
| 2 |
BC
Broadfin Capital
New York
|
+$5.47M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$1.5M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.11M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.66M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$2.1M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.34M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.31M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.08M |
ANGO Hedge Fund Activity: Q2 2014 in Review
109 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2014, worth a combined $378M — up 6.5% from $355M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ANGO positions and 13 closed out — a net gain of 1 holder — while 33 added to existing stakes and 46 trimmed.
The largest buyer was Paradigm Capital Management Inc, opening a new position worth an estimated $8.06M. The largest seller was Millennium Management, cutting an estimated $2.66M.
- 109 institutional investors held AngioDynamics (ANGO) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $378M of AngioDynamics stock for Q2 2014, up 6.5% quarter-over-quarter.
- 14 funds opened new AngioDynamics positions in Q2 2014 and 13 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q2 2014 was Paradigm Capital Management Inc, an estimated $8.06M added.
- The largest AngioDynamics seller in Q2 2014 was Millennium Management, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2014.